ET-D5

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameET-D5
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein phosphatase 1 inhibitors
TargetsProtein phosphatase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut CurieUniversité Joseph FourierCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversité Joseph FourierCentre National De La Recherche Scientifique (Cnrs)Ecrins Therapeutics SAS +[4] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A